Curt Labelle

Global health private equity

United States

Overview 

Curt LaBelle is the Managing Partner at AXA IM Global Health Private Equity, with a background in impact investing and growth capital. His career highlights include serving on the boards of various healthcare companies and holding leadership roles in global health private equity. LaBelle has a strong educational background with an MBA from Columbia Business School and an MD from Columbia University Vagelos College of Physicians and Surgeons, and his expertise lies in ophthalmology and venture financing within the healthcare sector.

Work Experience 

AXA IM Global Health Private Equity

  • Managing Partner

    2022 - Current

    Investments in companies developing therapeutics and diagnostics with attractive financial upside and the potential to address healthcare needs globally. Focus on late clinical and early commercial stage companies with target deployment of ~$30m per company.

AXA IM Prime Impact Fund

  • Advisor

    2020

    Our team recommends and manages healthcare investments for the AXA IM Prime Impact Fund. We invest in therapeutic and diagnostic companies that can improve health globally and generate strong financial returns. Investments include Alydia Health (acquired by Organon), Z Optics, Revelation Bio, Eyenuk, Ophirex and Biolinq.

NI

Novocuff, Inc.

  • Board Member

    2024

    Novocuff is a clinical stage company developing solutions for premature labor

VB

Vedanta Biosciences, Inc.

  • Board Member

    2023

Vedanta Biosciences creates microbiome-derived therapies to address immune and infectious diseases by modulating the gut microbiota.

Raised $436,994,519.00 from CARB-X.

vedantabio.com
ET

Epion Therapeutics

  • Board Member

    2022

    Epion is a late-stage clinical company developing novel treatments for keratoconus

Maternal Newborn Health Innovations

  • Board Member

    2022

    MNHI is developing solutions to make labor and delivery safer for mothers and babies.

OI

Ophirex, Inc.

  • Board Member

    2022

    Solutions for snakebites

Z Optics

  • Chair Of The Board Of Directors

    2020

    Intraocular lens aiming to offer accurate vision from near to far.

Atticus Medical

  • Member, Board of Directors

    2015

    Developing novel therapy for River Blindness. Sold Priority Review Voucher.

Serum Institute

  • Chair, Steering Committee

    2017 - 2023

    Collaboration with the Serum Institute of India to develop high quality anti-venoms for the developing world, and novel treatments for tuberculosis and bladder cancer.

Education 

Articles About Curt

Relevant Websites